Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Risky Business: Evolving Risks Across Workers’ Comp

A message from the Chief Executive Officer
Summer 2023

More than Skin-Deep: Untangling Topical Drug Classes and Costs

A breakdown of the diverse subcategories comprising dermatologicals prescribing and spend
Summer 2023

Unpredictable Costs: How Will Healthcare Price Inflation Impact Workers’ Comp?

Prices are rising for some healthcare products and services that will likely impact workers' compensation medical care
Summer 2023

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

New Autoimmune Biosimilar Approved and Alzheimer’s Drug Goes Generic

Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.
Mar 2024

Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

As the market grows, it becomes necessary to understand efficacy, costs, and alternatives.
Mar 2024

CWCI Reports on Cumulative Trauma in Litigated Claims

Tenure more than age and other factors had a higher association with cumulative trauma claims.
Mar 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020
1 2 3 4

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle